Epigenetic Inheritance
Impact for Biology and Society
Below you find the past Epigenetic Inheritance symposia, organized by Isabelle Mansuy, dedicated to the theme of epigenetic inheritance, a discipline at the interface between biology, medicine and environmental science that studies how life experiences and environmental factors modify the organism across generations. For every symposium, Isabelle gathers leaders from different disciplines working on epigenetic inheritance, to cover aspects from behavior to metabolism in humans and animal models. The symposium features keynote lectures from leaders in the field and short talks from young researchers and dedicated poster sessions.
It provides a platform for discussion and debate about the current state of research, new findings and discoveries, challenges of the discipline and perspectives for biology, medical research and the society at large.
Symposium 2023
23–25 August, ETH Zurich
Speakers
Bruce Blumberg, University of California Irvine, USA
Charlotte Cecil, Erasmus Medical Center, The Netherlands
Ina Dobrinski, University of Calgary, Canada
Andrew Feinberg, Johns Hopkins University, USA
Katharina Gapp, ETH Zurich, Switzerland
Carlos Guerrero Bosagna, Uppsula University, Sweden
Eric Greer, Washington University, St. Louis, USA
Jamie Hackett, European Molecular Biology Laboratory, Italy
Simone Immler, University of East Anglia, UK (unfortunately cancelled)
Sarah Kimmins, McGill University, Canada
Martin Lind, Uppsala University, Sweden (unfortunately cancelled)
Susan Ozanne, University of Cambridge, UK
Bing Ren, University of California San Diego, USA
Aurora Ruiz-Herrera, Autonomous University of Barcelona, Spain
Michael Skinner, Washington State University, USA
Jacquetta Trasler, McGill University, Canada
Ramji Bhandari, University of North Carolina at Greensboro, USA
Chamseddine Kifagi, Active Motif, Europe
Ali Jawaid, Nencki Institute of Experimental Biology, Poland
Yuta Takahashi, Altos Labs Institute of Science, USA
Raffaele Teperino, Helmholtz Diabetes Center, Munich, Germany
Workshop
“Questions and Challenges of the Field of Epigenetic Inheritance”
Co-organized with the Sir John Templeton Foundation
Sponsors
University Zurich
ETH Zurich
John Templeton Foundation
Socorex Swiss
Active Motif
SNSF Foundation
Symposium 2021
25–27 August, Online
Speakers
Jordana Bell, King’s College London, UK
Gavin Kelsey, The Babraham Institute, UK
Noora Kotaja, University of Turku, Finland
Brett Nixon, University of Newcastle, Australia
Anita Öst, Linköping University, Sweden
Wolf Reik, The Babraham Institute, UK
Kai Kleber, Dovetails Genomics, UK
Bermans Iskandar, University of Wisconsin, USA
Anar Alshanbayeva, University of Zurich and ETH Zurich, Switzerland
Emilie Rissman, North Carolina State University, USA
Michael Skinner, Washington State University, USA
Cecilie Svanes , University of Bergen, Norway
Fuchou Tang, Beijing Advanced Innovation Center for Genomics, Peking University, China
Adam Watkins, University of Nottingham, UK
Workshop
“Meet the Experts: Questions and Answers”
Co-organized with the Sir John Templeton Foundation
Sponsors
University Zurich
ETH Zurich
John Templeton Foundation
Socorex Swiss
Vitaris - A difference in Life Science
Dovetail Genomics - An EdenRoc Sciences Company
SNSF Foundation
Symposium 2019
26–28 August, ETH Zurich
Speakers
Patrick Allard, University of California, Los Angeles, USA
Tracie Baker, Wayne State University, Detroit, USA
Ramji Bhandari, University of North Carolina, Greensboro, USA
Romain Barrès, University of Copenhagen, Denmark
Qi Chen, University of California, Riverside, USA
Victor Corces, Emory University, Atlanta, USA
Lucia Daxinger, Leiden University Medical Center, Netherlands
Jill Escher, Escher Fund for Autism, USA
Larry Feig, Tufts University, Boston, USA
Anne Ferguson-Smith, University of Cambridge, UK
Valérie Grandjean, University of Nice Sophia Antipolis, France
Ali Jawaid, University and ETH Zurich, Switzerland
Alexander Meissner, Max-Plank Institute for Molecular Genetics, Germany
Gerlinde AS Metz, University of Lethbridge, Canada
Marcus Pembrey, UCL Great Ormond Street Institute of Child Health, UK
Michael Penkler; Munich Center for Technology in Society, DE
Antoine Peters, Friedrich Miescher Institute for Biomedical Research, Switzerland
Andrew Pospisilik, Van Andel Institute, Grand Rapids, USA
Mark Robinson, University of Zurich, Switzerland
Rose Schrott, Duke University, Durham, USA
Julia Schröder, Imperial College London, UK (unfortunately cancelled)
Upasna Sharma, University of California, Santa Cruz, USA
Michael Skinner, Washington State University, Pullman, USA
Corrado Spadafora, Italian National Research Council, Italy
Azim Surani, University of Cambridge, UK
Workshop
“Questions and Challenges of the Field of Epigenetic Inheritance”
Co-organized with the Sir John Templeton Foundation
Sponsors
University Zurich
ETH Zurich
John Templeton Foundation
Swiss National Science Foundation
Zentrum für Labormedizin
illumina
ETH Zurich - Institute for Neuroscience
Socorex Swiss
Merck
milian - Dutscher Group
Agilent - Trusted Answers
Janvier Labs
Carl Roth
Active Motif
diagenode - Innovating Epigenetics Solutions
Macherey-Nagel
Vitaris - A Difference in Life Science
Latsis Symposium 2017
28–30 August, ETH Zurich
Speakers
Marine Baptissart, North Carolina State University, USA
Marisa Bartolomei, University of Pennsylvania, USA
Stephan Beck, University College London, UK
Christoph Bock, Austrian Academy of Sciences, Vienna, Austria
Liran Carmel, Hebrew University of Jerusalem, Israel
Jill Escher, Escher Fund for Autism of San Jose, USA
Katharina Gapp, Sanger Institute, Cambridge, UK
Johannes Graeff, Ecole Polytechnique Fédérale, Lausanne, Switzerland
Carlos Guerrero-Bosagna, Linköping University, Sweden
Leah Houri-Ze’evi, Tel Aviv University, Israel
Eva Jablonka, Tel Aviv University, Israel
Josep Jiménez-Chillarón, Hospital Sant Joan de Deu, Barcelona, Spain
Maurizio Meloni, University of Sheffield, UK
Eric Miska, University of Cambridge, UK
Ruth Müller, Technical University Munich, Germany
Marcus Pembrey, University College London, UK
Vardhman Rakyan, Blizard Institute, London, UK
Minoo Rassoulzadegan, University of Nice, France
Abhay Sharma, CSIR-Institute of Genomics and Integrative Biology, India
Michael Skinner, Washington State University, USA
Adelheid Soubry, Catholic University Leuven, Belgium
Peter Spork, Economic author, Hamburg, Germany
Moshe Szyf, McGill University, Montreal, Canada
Jorg Tost, Commissariat à l’Energie Atomique, Evry, France
Gretchen van Steenwyk, University and ETH Zurich, Switzerland
Rachel Yehuda, Mount Sinai Hospital, New York, USA
1st edition
Transgenerational Epigenetic Inheritance:
Impact for Biology and Society
The Latsis Symposium 2017 is motivated by the wish and strong need to discuss and debate about the novel field of transgenerational epigenetic inheritance, an emerging discipline that is currently revolutionizing biology and is bringing novel perspectives for medical research and the society. The field addresses a key question in biology: What mediates heredity.
While it was thought to have been resolved by genetics, this question has re-emerged in the post-genomic era because of the recognition that there is more to an organism than its gene sequences. The question is considered one of the most burning and urgent to answer to date.
The main aim of the Latsis 2017 symposium is to discuss the breadth of biological phenomena involving epigenetics and their importance for transgenerational inheritance. The conference focuses on the issue of cross- and transgenerational inheritance of traits acquired by environmental exposure and personal experiences, a major mode of transmission that works outside classical Mendelian inheritance. Epigenetics is one of the most active and vibrant disciplines in biomedical research. It is of key importance because it not only provides new fundamental knowledge about basic mechanisms of biology but it also addresses critical medical issues. The identification of epigenetic marks and processes such as DNA methylation, histone posttranslational modifications and non-coding RNAs are moving the understanding of biological functions forward. Large-scale mapping projects have started to provide increasingly rich descriptions of the epigenome but have still incompletely answered questions about the role of these biochemical marks. Meanwhile there is growing interest in the therapeutic potential of epigenetic drugs that can modulate the epigenetic landscape and possibly have therapeutic actions that other drugs do not have. Genes encoding proteins that read, write or erase epigenetic marks are often mutated in neurological, psychiatric and metabolic diseases and in cancer, and are therefore key targets for potential innovative treatments.
Sponsors
The symposium is supported by the Latsis Foundation